Phase III quality-of-life study results: Impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer - RTOG 97-09

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 3, 2003, Pages 832-836

  Fisher, Jacquelyn ^a   Scott, Charles ^b   Scarantino, Charles W ^c   Leveque, Fran G ^d   White, Robert L ^e   Rotman, Marvin ^f   Hodson, D I ^g   Meredith, Ruby F ^h   Foote, Robert ⁱ   Bachman, David G ^j   Lee, Nancy ^k  

^a Edith McNaughton Ford Ctr R   (United States)

^b RTOG Statistical Unit   (United States)

^c Rex Cancer Center   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e WASHINGTON CANCER INSTITUTE   (United States)

^f SUNY DOWNSTATE MEDICAL CENTER   (United States)

^g Hamilton Regional Centre   (Canada)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁱ MAYO CLINIC   (United States)

^j Foundation for Cancer Research and Education   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Head and neck; Hyposalivation; Pilocarpine; Xerostomia

Indexed keywords

NUTRITION; ONCOLOGY; TUMORS;

SALIVARY FUNCTIONS;

RADIOTHERAPY;

PILOCARPINE; PLACEBO;

ADULT; ARM; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENDER; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; HYPOSALIVATION; MAJOR CLINICAL STUDY; MALE; MASTICATION; MUCOSA INFLAMMATION; NUTRITIONAL SUPPORT; PAIN; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; QUALITY OF LIFE; RACE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SALIVA ANALYSIS; SALIVARY GLAND; SAMPLING; SCORING SYSTEM; SMOKING HABIT; STATISTICAL SIGNIFICANCE; TASTE; TOBACCO; TREATMENT OUTCOME; XEROSTOMIA;

EID: 0037605893     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00121-4     Document Type: Article

References (8)

1. Rieke J.W., Haferman M.D., Johnson J.T., et al. Oral pilocarpine for radiation-induced xerostomia Integrated efficacy and safety results from two prospective randomized trials . Int J Radiat Oncol Biol Phys. 31:1995;661-669.
2. Leveque F.G., Montgomery M., Potter D. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol. 11:1993;1124-1131.
3. Johnson J.T., Ferretti G.A., Nethery W.J. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med. 329:1993;390-395.
4. Cella D.F., Cherin E.A. Quality of life during and after cancer treatment. Comp Ther. 14:1988;69-75.
5. Peterman A., Cella D., Glandon G. Mucositis in head and neck cancer economic and quality of life outcomes . J Natl Cancer Inst. 29:2001;45-51.
6. Kahn S.B., Houts P.S., Harding S.P. Quality of life and patients with cancer A comprehensive study of patients vs physician perceptions and its implications for cancer education . J Cancer Ed. 7:1992;241-249.
7. Hassan S.J., Weymuller E.A. Assessment of quality of life in head and neck cancer patients. Head Neck. 15:1993;485-496.
8. Scarantino C.W., LeVeque F.G., Scott C.B. A phase III study of concomitant oral pilocarpine to reduce hyposalivation and mucositis associated with curative radiation therapy in head and neck cancer patients (RTOG 97-09). Proceedings from the American Society of Clinical Oncology (ASCO), San Francisco, CA. J Clin Oncol. 51:2001;146-148.